Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer

Annals of Surgical Oncology

Volumn 16, Issue 12, 2009, Pages 3388-3395

  Hatoum, Hassan A ^a   Jamali, Faek R ^a   El Saghir, Nagi S ^a   Musallam, Khaled M ^a   Seoud, Muhieddine ^a   Dimassi, Hani ^b   Abbas, Jaber ^a   Khalife, Mohamad ^a   Boulos, Fouad I ^a   Tawil, Ayman N ^a   Geara, Fadi B ^a   Salem, Ziad ^a   Shamseddine, Achraf A ^a   Al Feghali, Karine ^a   Shamseddine, Ali I ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b LEBANESE AMERICAN UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER THERAPY; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 71549126800     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0653-8     Document Type: Article

References (40)

1. A Jemal R Siegel E Ward, et al. 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 10.3322/CA.2007.0010 18287387
2. DL Morton 1997 Intra-operative lymphatic mapping and sentinel lymphadenectomy: community standard care or clinical investigation? Cancer J Sci Am 3 328 330 1:STN:280:DyaK1c%2Fms1OntA%3D%3D 9403042
3. MA Kutiyanawala M Sayed A Stotter, et al. 1998 Staging the axilla in breast cancer: an audit of lymph-node retrieval in one UK regional centre Eur J Surg Oncol 24 280 285 10.1016/S0748-7983(98)80006-1 1:STN:280: DyaK1czpt1ajtw%3D%3D 9724993
4. A Smeets MR Christiaens 2005 Implications of the sentinel lymph node procedure for local and systemic adjuvant treatment Curr Opin Oncol 17 539 544 10.1097/01.cco.0000183542.63675.66 16224230 (Pubitemid 41566405)
5. T Schulze J Mucke J Markwardt, et al. 2006 Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection J Surg Oncol 93 109 119 10.1002/jso.20406 16425290 (Pubitemid 43235256)
6. WA Woodward EA Strom SL Tucker, et al. 2003 Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival J Clin Oncol 21 3244 3248 10.1200/JCO.2003.03.052 12947058 (Pubitemid 46606256)
7. A Recht R Gray NE Davidson, et al. 1999 Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group J Clin Oncol 17 1689 1700 1:CAS:528:DyaK1MXktV2qtLo%3D 10561205
8. A Taghian JH Jeong E Mamounas, et al. 2004 Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials J Clin Oncol 22 4247 4254 10.1200/JCO.2004.01.042 15452182 (Pubitemid 41185145)
9. V Vinh-Hung T Burzykowski G Cserni, et al. 2003 Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer Int J Oncol 22 697 704 12579326
10. V Vinh-Hung G Cserni T Burzykowski, et al. 2003 Effect of the number of uninvolved nodes on survival in early breast cancer Oncol Rep 10 363 368 12579273
11. DN Krag RM Single 2003 Breast cancer survival according to number of nodes removed Ann Surg Oncol 10 1152 1159 10.1245/ASO.2003.03.073 14654470 (Pubitemid 40486809)
12. BC van der Wal RM Butzelaar S van der Meij, et al. 2002 Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer Eur J Surg Oncol 28 481 489 10.1053/ejso.2002.1239 12217299 (Pubitemid 35446775)
13. M Voordeckers V Vinh-Hung J Van de Steene, et al. 2004 The lymph node ratio as prognostic factor in node-positive breast cancer Radiother Oncol 70 225 230 10.1016/j.radonc.2003.10.015 15064006 (Pubitemid 38520153)
14. V Vinh-Hung C Verschraegen DI Promish, et al. 2004 Ratios of involved nodes in early breast cancer Breast Cancer Res 6 R680 R688 10.1186/bcr934 15535850
15. PT Truong E Berthelet J Lee, et al. 2005 The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes Cancer 103 2006 2013 10.1002/cncr.20969 15812825 (Pubitemid 40605106)
16. B Kuru 2006 Prognostic significance of total number of nodes removed, negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma Eur J Surg Oncol 32 1082 1088 10.1016/j.ejso.2006.06. 005 1:STN:280:DC%2BD28novVeqsQ%3D%3D 16887320 (Pubitemid 44774399)
17. I Lale Atahan F Yildiz G Ozyigit, et al. 2008 Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer Acta Oncol 47 232 238 10.1080/02841860701678761 17924207 (Pubitemid 351164892)
18. V Vinh-Hung HM Verkooijen G Fioretta, et al. 2009 Lymph node ratio as an alternative to pN staging in node-positive breast cancer J Clin Oncol 27 1062 1068 10.1200/JCO.2008.18.6965 19164210
19. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 6th ed. New York, NY: Springer; 2002.
20. EN Atkinson BW Brown ED Montague 1986 Tumor volume, nodal status, and metastasis in breast cancer in women J Natl Cancer Inst 76 171 178 1:STN:280:DyaL287hs1ahuw%3D%3D 3456058
21. CL Carter C Allen DE Henson 1989 Relation of tumor size, lymph node status, and survival in 24, 740 breast cancer cases Cancer 63 181 187 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H 1:STN:280:DyaL1M%2FovFCqug%3D%3D 2910416 (Pubitemid 19032001)
22. RJ Gray 1992 Flexible methods for analyzing survival data using splines, with application to breast cancer prognosis J Am Stat Assoc 87 942 951 10.2307/2290630
23. SG Hilsenbeck PM Ravdin CA de Moor, et al. 1998 Time-dependence of hazard ratios for prognostic factors in primary breast cancer Breast Cancer Res Treat 52 227 237 10.1023/A:1006133418245 1:STN:280:DyaK1M7mtl2lug%3D%3D 10066085 (Pubitemid 29056098)
24. W Sauerbrei P Royston H Bojar, et al. 1999 Modelling the effects of standard prognostic factors in nodepositive breast cancer: German Breast Cancer Study Group (GBSG) Br J Cancer 79 1752 1760 10.1038/sj.bjc.6690279 1:STN:280:DyaK1M3itFWhuw%3D%3D 10206288
25. KM McMasters 2003 The eternally enigmatic axilla: further controversy about axillary lymph node in breast cancer Ann Surg Oncol 10 1128 1130 10.1245/ASO.2003.10.917 14654464 (Pubitemid 40486803)
26. Early Breast Cancer Trialists Collaborative Group 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 17 1687
27. Early Breast Cancer Trialists' Collaborative Group 2005 Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15- year survival: an overview of the randomised trials Lancet 366 2087 2106
28. MM Baslaim OA Al Malik SS Al Sobhi, et al. 2002 Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy Am J Surg 184 299 301 10.1016/S0002-9610(02)00959-5 12383887 (Pubitemid 35287345)
29. M Kyndi FB Sørensen H Knudsen 2008 et al. Danish Breast Cancer Cooperative Group. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group J Clin Oncol 26 1419 1426 10.1200/JCO.2007.14.5565 1:CAS:528:DC%2BD1cXkslKqs7c%3D 18285604
30. The Steering Committee on Clinical Practice 1998 Guidelines for the care and treatment of breast cancer CMAJ 158 Suppl 3 S1 S2
31. L Weir C Speers Y D'Yachkova, et al. 2002 Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer J Clin Oncol 20 1793 1799 10.1200/JCO.2002.07.112 1:STN:280: DC%2BD387oslKlsQ%3D%3D 11919236 (Pubitemid 34273268)
32. B Fowble LJ Solin DJ Schultz, et al. 1989 Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer Int J Radiat Oncol Biol Phys 17 703 710 1:STN:280:DyaL1MznvF2hsw%3D%3D 2550398
33. RK Orr 1999 The impact of prophylactic axillary node dissection on breast cancer survival-a Bayesian meta-analysis Ann Surg Oncol 6 109 116 10.1007/s10434-999-0109-1 1:STN:280:DyaK1M7ltlCqtg%3D%3D 10030423 (Pubitemid 29077496)
34. R Chaudhry V Goel C Sawka 2001 Breast cancer survival by teaching status of the initial treating hospital CMAJ 164 183 188 1:STN:280: DC%2BD3M3mt1ClsA%3D%3D 11332310
35. JA Sosa M Diener-West Y Gusev, et al. 1998 Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer Ann Surg Oncol 5 140 149 10.1007/BF02303847 1:STN:280: DyaK1c7os1CqtQ%3D%3D 9527267 (Pubitemid 29071283)
36. WE Gillanders K Mikhitarian R Hebert, et al. 2004 Molecular detection of micrometastatic breast cancer in histopathologynegative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study Ann Surg 239 828 837 10.1097/01.sla.0000128687.59439.d6 15166962 (Pubitemid 38669433)
37. G Cserni S Bianchi W Boecker, et al. 2005 Improving the reproducibility of diagnosing micrometastases and isolated tumor cells Cancer 103 358 367 10.1002/cncr.20760 15593354 (Pubitemid 40129296)
38. RR Turner DL Weaver G Cserni, et al. 2008 Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training J Clin Oncol 26 258 263 10.1200/JCO.2007.13.0179 18182666
39. GH Sakorafas AG Tsiotou BM Balsiger 2000 Axillary lymph node dissection in breast cancer-current status and controversies, alternative strategies and future perspectives Acta Oncol 39 455 466 10.1080/028418600750013366 1:STN:280:DC%2BD3cvovFygtg%3D%3D 11041107
40. NJ Bundred DA Morgan JM Dixon 1994 ABC of breast diseases. Management of regional nodes in breast cancer Br Med J 309 1222 1225 1:STN:280: DyaK2M%2FnvVKltA%3D%3D